Locoregionally Advanced, BRAF V600L-Positive, Mucosal Melanoma of the Hypopharynx Treated With a Combination of BRAF and MEK Inhibitors

Affiliations

• ¹ Faculty of Medicine, Sherbrooke University, Sherbrooke, QC, Canada.
• ² Department of Oncology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
• ³ Department of Pathology, Montreal University Hospital Center, Montreal, QC, Canada.
• ⁴ Department of Pathology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
• ⁵ Division of Otolaryngology-Head and Neck Surgery, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
• ⁶ Department of Experimental Surgery, McGill University, Montreal, QC, Canada.
• ⁷ Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.